Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Agile Therapeutics Inc. buy Maxim Group

Start price
€0.21
22.09.23 / 50%
Target price
-
22.09.24
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 22.09.24. The prediction end date can be changed by Maxim_Group at any time.
Performance without dividends (%)
Name 1w 1m
Agile Therapeutics Inc. - -
iShares Core DAX® 3.178% 0.980%
iShares Nasdaq 100 2.972% 0.925%
iShares Nikkei 225® 0.545% -4.556%
iShares S&P 500 2.367% 0.833%

Comments by Maxim_Group for this prediction

In the thread Agile Therapeutics Inc. diskutieren

Agile Therapeutics, Inc. (NASDAQ: AGRX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for AGRX provided by MarketBeat